Yuan Rong
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 7
- Cancer Genomics and Diagnostics 4
- Immunology top 10%
- Immune cells in cancer 4
- interferon and immune responses 2
- Oncology top 10%
- Cancer Cells and Metastasis 3
- Molecular Biology top 10%
- Circular RNAs in diseases 4
- RNA modifications and cancer 3
- Genetics top 10%
- Co-authors
- Fubing WangKezhen YiLanxiang HuangChunhui YuanDaniel J. BratErwin G. Van MeirXuan TangWeihuang Liu
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Scientific Reports (2 papers)Frontiers in Molecular Biosciences (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yuan Rong
25 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 507
- Immunology 337
- Oncology 320
- Molecular Biology 799
- Genetics 119
Countries citing papers authored by Yuan Rong
This map shows the geographic impact of Yuan Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Rong more than expected).
Fields of papers citing papers by Yuan Rong
This network shows the impact of papers produced by Yuan Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Rong. The network helps show where Yuan Rong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuan Rong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 17 | |
| 5 | 2022 | 13 | |
| 6 | Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancerbreakdown → | 2022 | 297 |
| 7 | 2022 | 4 | |
| 8 | 2021 | 25 | |
| 9 | 2020 | 54 | |
| 10 | 2020 | 37 | |
| 11 | 2019 | 17 | |
| 12 | 2018 | 25 | |
| 13 | 2018 | 14 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 21 | |
| 16 | 2016 | 175 | |
| 17 | 2016 | 64 | |
| 18 | 2013 | 55 | |
| 19 | 2012 | 179 | |
| 20 | 2012 | 17 |
About Yuan Rong
Yuan Rong is a scholar working on Cancer Research, Aging, Immunology, Molecular Biology and Oncology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (4 papers), Immune cells in cancer (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (507 citations), Immunology (337 citations), Oncology (320 citations), Molecular Biology (799 citations) and Genetics (119 citations). Yuan Rong has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Fubing Wang, Kezhen Yi, Lanxiang Huang, Chunhui Yuan, Daniel J. Brat, Erwin G. Van Meir, Xuan Tang, Weihuang Liu, Xing Gao and Jinxuan Hou. Their work appears in journals such as Scientific Reports, Frontiers in Molecular Biosciences, Oncotarget, Molecular Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.